Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited, headquartered in Mumbai, India, and established in 2019 (originally Aarti Organics Limited), primarily focuses on the production and global distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. These vital compounds are utilized in medications across a wide range of therapeutic categories, including treatments for hypertension, asthma, cancer, central nervous system conditions, dermatological issues, congestion, cardiovascular diseases, thalassemia, pain management, diabetes, and ophthalmic disorders. Beyond its core offerings, the company is also involved in creating novel chemical entities (NCEs), regulatory starting materials (RSMs), basic and key starting materials (KSMs), essential building blocks, xanthine derivatives, and related chemical products. Moreover, Aarti Pharmalabs provides comprehensive contract development and manufacturing (CDMO) solutions. These services, covering drug substance projects like NCEs, APIs, RSMs, and intermediates, are extended to innovative pharmaceutical and biotechnology companies globally.